ஸ்யாக் ஸ்வீனி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்யாக் ஸ்வீனி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்யாக் ஸ்வீனி Today - Breaking & Trending Today

Interline lands $92m to map, correct dysfunctional proteins

The company reportedly will utilize the investment funding to expand its research platform, and to advance six of its preclinical therapeutic programs. ....

Zach Sweeney , Interline Therapeutics , Markets Amp Regulations , Preclinical Research , Drug Delivery , Clinical Development , Atient Centricity , Linical Evolution , Apis Active Pharmaceutical Ingredients , Research And Development , ஸ்யாக் ஸ்வீனி , சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள் ,

Startup Interline snares $92M from Foresite, ARCH to turn protein communities against common diseases

Startup Interline snares $92M from Foresite, ARCH to turn protein communities against common diseases
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United States , South San Francisco , San Francisco , Zach Sweeney , Anjanabha Saha , David Tully , Ron Leuty , Nick Galli , Mario Cardozo , Mike Varney , Don Kirkpatrick , Nevan Krogan , University Of California , Denali Therapeutics Inc , Interline Therapeutics Inc , Boehringer Ingelheim , Memorial Sloan Kettering Cancer Center John Chodera , Tularik Inc , Eikon Therapeutics Inc , Foresite Lab , Amgen Inc , Nurix Therapeutics Inc , Staff Reporter , San Francisco Business Times , Therapeutics Inc , Foresite Capital ,

Foresite, Arch fuel $92M round for Interline Therapeutics, a biotech taking aim at protein communities

We often think of proteins as isolated targets for drugs, says Zach Sweeney, Ph.D., a biopharma veteran who most recently was chief scientific officer at Denali Therapeutics. But it's more complicated than that. Enter Interline Therapeutics, which launches with $92 million to develop drugs that alter protein communities to treat disease. ....

United States , San Francisco , Zach Sweeney , Don Kirkpatrick , University Of California , Memorial Sloan Kettering Cancer Center , Interline Therapeutics , Foresite Capital , Arch Venture Partners , Memorial Sloan Kettering Cancer , Foresite Capital Management , Arch Venture Partners , Drug Discovery , Inflammatory Diseases , Venture Capital Vc , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , ஸ்யாக் ஸ்வீனி , தாதா கர்க்‌ப்யாட்ரிக் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் மையம் , வளைவு துணிகர கூட்டாளர்கள் , நினைவகம் ஸ்லோன் கெட்டரிங் புற்றுநோய் ,